Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

dolutegravir-lamivudine

dolutegravir-lamivudine
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Dovato TABLET, ORAL 50-300 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

dolutegravir-lamiVUDine (Dovato)

  • 50 mg-300 mg tablet

dolutegravir (Tivicay) AND lamiVUDine (Epivir)

  • ONE 50 mg dolutegravir tablet PLUS ONE 300 mg lamiVUDine tablet

Non-formulary, not stocked. Dispense as individual components. Inpatients may use their home supply.

Reviewed: 23 July 2019

Last updated: Aug. 2, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved